ekonominyheter

TranslateRSSMobil
Why Regulus Therapeutics Inc. Stock More Than Doubled

Why Regulus Therapeutics Inc. Stock More Than Doubled

Fool.com 22/10 16:46

Regulus Therapeutics is today's best biotech stock as its shares more than doubled following the release of positive interim hepatitis C drug data.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status